|
| Exchange Disseminated Time 01/11/2016 10:41:53 | Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be
held on November 11, 2016, inter alia, to consider, the Unaudited Financial Results for the quarter and half year ended
September 30, 2016, and related matters (Q2).
Further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 Trading Window for dealing in the securities of the Company will be closed from November 01, 2016 to November 13, 2016 (both days inclusive). Trading window will be opened from November 14, 2016. |
|
|